Lot Release Certificate View

Lot Release Number 2021-07-14-0341
FDA Registered Product/Generic Name DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B, POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED) [DTap-IPV-HepB-Hib]
Brand Name HEXAXIM
Dosage Strength 0.5 mL
Dosage Form SUSPENSION FOR INJECTION (I.M.)
Registration Number BR-919
Batch/Lot Number U3B62
Packaging Lot Packaging Lot (Box): U3B622V; (PFS): U3B62; (Needle 23G x 1"): 2006013; (Needle 25G x 5/8"): 2007032
Product Expiration Date 30 November 2022
Issuance Date 16 July 2021